Morgan Stanley (NYSE:MS) initiated coverage on shares of GlaxoSmithKline (NYSE:GSK:LN) (NYSE: GSK), a $72.5 billion pharmaceutical giant with a 25-year track record of consistent dividend payments, ...

GSK PLC closed 20.84% below its 52-week high of £18.24, which the company achieved on May 16th.

GSK announced several transactions involving the vesting and sale of ordinary shares under its Performance Share Plan and Deferred Investment Award Programme. The transactions involve key executives, ...

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...

A few notable health care deals along with M&A in the AI-adjacent and reshoring themes occurred in January. Read more here.

To offer further encouragement, Dame Emma Walmsley, the company’s chief, offered a more optimistic outlook than expected for 2025. The company steered expectations toward an increase of 3 to 5pc in ...

Shares of GSK PLC GSK advanced 1.56% to £14.66 Monday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.77% to 8,767.80. GSK PLC ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...

The shortage of certain types of influenza vaccines could end as early as next month with the arrival of new stock, says ...

DAVENPORT & Co LLC lessened its position in shares of GSK plc (NYSE:GSK – Free Report) by 4.0% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission.

Harvey Jones has something to celebrate after a positive set of results boosted the GSK share price after a disappointing run ...

Willscot Mobile Mini (NASDAQ: WSC) stock climbed 3.6% mid-day Thursday, following news that the Trump administration is negotiating with the company to lease its ...